Top Markets
#1 Islamic Coin Islamic Coin +151.65%
#2 Black Phoenix Black Phoenix +30.37%
#3 Palladium Network Palladium Network +19.14%
#4 Not in Employment, Education, or Training Not in Employment, Education, or Training +17.95%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.95%
#6 Fake World Assets Fake World Assets +13.36%
#7 clBTC clBTC +12.17%
#8 Akedo Akedo +11.20%
#9 Wrapped Ether (Mantle Bridge) Wrapped Ether (Mantle Bridge) +8.90%
#10 Mantle Staked Ether Mantle Staked Ether +8.50%
Coin of the day
Islamic Coin Islamic Coin
설정
언어
한국어
통화
USD
테마
PCI Biotech Holding ASA PCI Biotech Holding ASA

PCI Biotech Holding ASA

PCIB
주식 순위 #40012
PCI Biotech Holding ASA, an Oslo, Norway-based biopharmaceutical firm, is... PCI Biotech Holding ASA, an Oslo, Norway-based biopharmaceutical firm, is focused on pioneering and bringing to market innovative treatments for cancer. At the core of their operations is the proprietary photochemical internalization (PCI) technology platform. The company's development pipeline features several distinct therapeutic strategies: fimaCHEM, a novel approach to chemotherapeutic cancer treatment; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is currently in Phase I clinical studies; and fimaNAc, a delivery system for nucleic acid therapeutics, presently in its pre-clinical phase. Furthermore, they provide Amphinex, a photosensitizer known as fimaporfin. PCI Biotech actively participates in joint research endeavors with partners such as Bavarian Nordic, BioNTech, Phio Pharmaceuticals, DCprime, eTheRNA immunotherapies, IMV, and Aposense.
주가
$0.00733708
마지막 동기화: 2026-04-23
시가총액
$273.87K
변동 (1일)
-39.13%
변동 (1년)
-94.83%
국가
NO
거래 PCI Biotech Holding ASA (PCIB)

카테고리

Healthcare
PCI Biotech Holding ASA (PCIB)의 매출
Aug 2026 기준 매출 TTM: 0
PCI Biotech Holding ASA의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 0 대비 동일입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
PCI Biotech Holding ASA의 수익 기록 (2026 ~ 2026)
매년 말 매출
연도 매출 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE